Strana 1 od 25 výsledky
BACKGROUND OF THE INVENTION
Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side
REFERENCES
Safer than Phen-Fen (copyright 1997), Written by Michael Anchors, MD Ph.D. Pulmonary Vascular Disease, Medical Clinics of North America Nov. 6. 1997, Written by Donald Heath, MD Ph.D.
The "Phen-pro" Diet Drug Combination Is Not Associated with Valvular Heart Disease. Jan. 12, 1998
REFERENCES
Safer than Phen-Fen (copyright 1997), Written by Michael Anchors, MD Ph.D. Pulmonary Vascular Disease, Medical Clinics of North America Nov. 6, 1997, Written by Donald Heath, MD Ph.D.
The "Phen-pro" Diet Drug Combination Is Not Associated with Valvular Heart Disease. Jan. 12, 1998
BACKGROUND OF THE INVENTION
Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side
BACKGROUND OF THE INVENTION
Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side
BACKGROUND OF THE INVENTION
Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side
CROSS REFERENCES TO RELATED APPLICATIONS
This application claims priority to Japanese Patent Application No. 2004-134683, filed on Apr. 28, 2004.
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a food for ingestion by an obese person or a person concerned about an increase in body
BACKGROUND OF THE INVENTION
(i) Field of the Invention
The invention relates to amphetamine compounds, compositions and methods of delivery and use comprising amphetamine covalently bound to a chemical moiety.
The invention relates to compounds comprised of amphetamine covalently bound to a chemical
BACKGROUND OF THE INVENTION
(i) Field of the Invention
The invention relates to amphetamine compounds, compositions and methods of delivery and use comprising amphetamine covalently bound to a chemical moiety.
The invention relates to compounds comprised of amphetamine covalently bound to a chemical
PRIORITY
This application corresponds to the U.S. national phase of International Application No. PCT/EP2013/072772, filed Oct. 31, 2013, which, in turn, claims priority to European Patent Application No. 12.007446.3 filed Oct. 31, 2012, the contents of which are incorporated by reference herein in
BACKGROUND OF THE INVENTION
Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side
FIELD OF THE INVENTION
This invention discloses the first cellular acetylated substrate protein of SIRT3, Acetyl-CoA synthetase 2 (AceCS2), which is a mitochondrial matrix protein. The mitochondrial sirtuin SIRT3 interacts with AceCS2 and directly controls the activity of this metabolic enzyme via
FIELD OF THE INVENTION
This invention relates to compositions and methods for controlling the weight of animals.
BACKGROUND OF THE INVENTION
Animals, particularly companion animals (e.g., dogs and cats), may weigh more than their ideal body weight. Having an excess of adipose tissue, these animals
FIELD OF THE INVENTION
This invention relates to compositions and methods for controlling the weight of animals.
BACKGROUND OF THE INVENTION
Animals, particularly companion animals (e.g., dogs and eats), may weigh more than their ideal body weight. Having an excess of adipose tissue, these animals
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a US filing under 35 USC 371 of International Application No. PCT/US2007/062710 filed on Feb. 23, 2007, the contents of which are incorporated herein by reference.
FIELD OF THE INVENTION
This invention relates to compositions and methods